Lv31
290 积分 2021-04-21 加入
Short‐Term Weight Loss Outcomes of 1.0 mg Semaglutide Therapy Initiated 6 Months After Sleeve Gastrectomy
14天前
已完结
Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study
14天前
已完结
Why does GLP ‐1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP ‐1 agonist alone in obese adults without type 2 diabetes?
1个月前
已完结
Glucagon receptor antagonism requires further mechanistic attention on α-cell physiology
1个月前
已完结
Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non‐Diabetic Adults: A Meta‐Analysis of Randomised Controlled Trials
1个月前
已完结
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1个月前
已完结
The Diverse Roles of Lipid Metabolism Reprogramming in Shaping the Tumor Immune Microenvironment
1个月前
已完结
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
1个月前
已完结
Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment
1个月前
已关闭
皖公网安备34019202002308
